Prevalence, Awareness, Attitudes and Patterns of Stimulant Drug Use Among Students in Egyptian Universities
NCT ID: NCT06646822
Last Updated: 2025-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
1500 participants
OBSERVATIONAL
2024-12-10
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Illicit stimulants are usually schedule II, depending on whether or not they can be used to treat medical conditions. While some variations of stimulants are schedule I drugs, most are extremely addictive and dangerous schedule II substances. These drugs are often abused in a binge-crash pattern. According to the NIDA Teen, "In order to keep the 'high' going, people may take the drug repeatedly within a short period of time, at increasingly higher doses." This makes these drugs extremely addictive.
The aim of this survey to detect prevalence of non prescription stimulants in Egyptian students and increase their awareness of the harmful effects of these drugs.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use
NCT03648684
The Adaptation and Evaluation of the WHO's ASSIST-linked Brief Intervention to Khat-Using Ethiopian University Students
NCT03730805
Effect of Stimulant Drugs on Social Perception
NCT03790618
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
NCT05379959
French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students
NCT02954679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Students will receive survey through email. Students took the survey online at a time and location of their choice. No time limit was imposed. Participants will automatically routed through each section of the survey. First, students read a description of the study, including potential benefits and costs of taking the survey, and then they will be asked if they are a current undergraduate student at the participating university and their age. First section included the demographic data of participants, the second section the investigator will aske participants to indicate if they had ever been prescribed a stimulant. If participant answered yes, participants will route to the next section which asks about the frequency of use, the effects of stimulants and any complain if present.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
Undergraduate students at a large public university in Egypt who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy.
Students were received survey through email. Students took the survey online at a time and location of their choice.
questionnaire
observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire
observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asmaa Ahmed Hamed Mohie Eldin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asmaa Ahmed Hamed Mohie Eldin
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asmaa Ahmed Hamed
Minya, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MPEC 240704
Identifier Type: REGISTRY
Identifier Source: secondary_id
MPEC 240704
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.